Overview
SLS market data
Price History
SLS price chart · 1M
- O
- 14.01
- H
- 15.54
- L
- 13.99
- C
- 15.20
- Vol
- 269,536.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $14.01
- Previous Close
- $13.75
- Day High
- $15.54
- Day Low
- $13.99
- 52 Week High
- $15.86
- 52 Week Low
- $4.66
- 7 Day Return
- +13.43%
- 30 Day Return
- +50.79%
- 90 Day Return
- +63.35%
- 1 Year Return
- +224.79%
- Daily Notional Volume
- $4.1M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.51 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.58 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -736.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.39 – $15.88 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $2.5B · P/B 7.58 · P/S 847.51.
Company News
When Revolution Medicines' FDA Win Lifts Other Boats: SELLAS Life Sciences Stock SurgesBenzinga · Aug 27, 2026, 5:13 PM
Shares of mRNA cancer vaccine-related companies are trading higher amid sympathy with Merck and Moderna after they announced that intismeran autogene with KEYTRUDA yielded recurrence-free survival in patients with completely resected stage IIB-IV melanoma.Benzinga · Aug 19, 2026, 4:15 PM
SELLAS Life Sciences Gr Q2 EPS $(0.05) Misses $(0.04) EstimateBenzinga · Aug 11, 2026, 8:19 PM
SELLAS Says Arbitrator Dismisses Its Claims Against 3D Medicines, Orders SELLAS To Pay Approximately $1M In Legal FeesBenzinga · Jul 27, 2026, 8:42 PM
8-K filing — SELLAS Life Sciences Group, Inc. (SLS)SEC EDGAR · Jul 27, 2026, 8:35 PM
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On FridayBenzinga · Jul 17, 2026, 2:09 PM
SELLAS Life Sciences Shares Slip Wednesday as Price Tests $16 Resistance WallBenzinga · Jul 8, 2026, 3:15 PM
SELLAS Life Sciences Shares Fall Tuesday: What's Driving The Move?Benzinga · Jun 30, 2026, 1:45 PM
Sellas Life Sciences Shares Break Out To New 52-Week High: What's Driving The Momentum?Benzinga · Jun 29, 2026, 8:10 PM
Iridium Communications, FuelCell Energy, Rocket Lab And Other Big Stocks Moving Higher On MondayBenzinga · Jun 29, 2026, 2:00 PM